Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis
Pakistan Journal of Medical Sciences. 2017; 33 (6): 1507-1511
em Inglês
| IMEMR
| ID: emr-189415
ABSTRACT
Objectives:
To evaluate the effect of Atorvastatin as an adjuvant with betamethasone valerate on disease severity and cardiovascular risks in chronic plaque type psoriatic patients
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Pak. J. Med. Sci.
Ano de publicação:
2017
Similares
MEDLINE
...
LILACS
LIS